CareMetx, LLC

We were live in Philadelphia yesterday at the Informa Connect Patient Support Services Congress, leading conversations with other industry leaders on the future of #patientservices. Thank you for joining us for the panel on accelerating speed to therapy with embedded provider workflows! More to come today....??? ??

The annual reverification season presents a major challenge: processing a high volume of benefit verifications (BVs) in a short timeframe. Each BV is complex, involving millions of transactions across payers, providers, and patient services. While many hubs fall short, CareMetx is an industry leader, with a track record of completing 450,000 reverifications ahead of schedule each year. In our latest blog post, learn about the key strategies for planning, staffing, training, and automation that drive success for reverification season: https://hubs.ly/Q02YXZPv0

?? Tomorrow ?? Join Claudia Stemple, Michael Sullivan, George Moore, and Amanda Wilson for a thought-provoking discussion on Using Embedded Provider Workflows to Fast-Track Specialty Therapy Access at the Informa Connect Patient Support Services Congress. Panel description: The future of #patientservices is already here. Join industry leaders to explore the transformative impact of integrating core hub services directly into provider workflows. Learn how this streamlined approach accelerates key services like benefits verification and prior authorization approvals for patients. Gain insights on the real-world applications that have delivered measurable results for specialty pharmaceutical manufacturers. Learn more about the panel: https://lnkd.in/eB3ypF8p

Patients dealing with rare diseases are often under tremendous stress, balancing the demands of their treatment with daily life.?That’s why it’s so important for the hubs that support them to accommodate them --- in big ways and little ways – at every step of the patient journey. Melissa Paige Founder of the Healthcare Advocate Summit and the National Association of Medication Access & Patient Advocacy (NAMAPA) shares, “A hub that meets patients where they are—whether that means communicating in their preferred language, finding alternative ways to reach them, or simply offering a consistent and caring presence---can make all the difference in the patient’s experience.” Read more from Melissa here: https://lnkd.in/em37pfQt

If you’re first to market for a rare disease therapy, you won’t find a hub vendor with disease-specific experience, but you should expect a deep understanding of the unique complexities of rare disease drugs—like strict and laborious administration regimens, extensive diagnostic testing, and regular monitoring. Learn more by downloading the guide to launching therapies for rare diseases: https://lnkd.in/eNC3nmyG

Are your medical benefit reverifications returning enough information? Learn how a single detail can change medication access and why BVs need to be more comprehensive than you might think. Read our latest blog post: https://lnkd.in/eiqTSkNp

CareMetx will be attending the Informa Connect Patient Support Services Congress in Philadelphia! Book time to meet with us there: https://lnkd.in/eDsABX5h Please reach out to Emily Tower, Glenn M. Esgro, Darren Stefano, Adam Bridges or Shabbir Ahmed if you want to connect at the conference and learn more about CareMetx’s patient support services. We’re also hosting a panel discussion on Using Embedded Provider Workflows to Fast-Track Specialty Therapy Access. Looking forward to an amazing two days of insightful conversations!

A fragmented ecosystem. A scattering of stakeholders. A disjointed process. Getting patients on their specialty therapies is no easy feat. In a new article for Drug Channels Institute, an HMP Global Company, CareMetx’s Chief Commercial Officer Shabbir Ahmed explores new ways manufacturers can partner with providers to create unprecedented connectivity and dramatically simplify the path to access. Read the post: https://lnkd.in/eZbuN6hU

In the latest episode of the Prescription for Better Access podcast, Mark Hansan (He/Him) moderates a discussion on how different regulatory environments, drug pricing controls, and reimbursement processes impact patient access to new therapies—and what the U.S. can learn from international approaches. Featuring: Nikos Maniadakis, Kimberly Baldwin, Fauzea Hussain - Tune in now! https://lnkd.in/ez2hQ2aD or Spotify https://lnkd.in/eXZqFih9

Join us at the Informa Patient Support Services Congress for an insightful panel on Using Embedded Provider Workflows to Fast-Track Specialty Therapy Access. Featuring: Claudia Stemple RN, BSN, MBA, Director, Value & Access Consulting, Syneos Health With over 20 years in the pharmaceutical and biotechnology industry, Claudia has specialized in managed care, patient access, hub services, and provider workflow optimization. She is a healthcare leader with a deep understanding of reimbursement and the payer landscape, driving innovation at companies like Novartis, Regeneron, and Amgen. As a registered nurse with an MBA, Claudia excels in transforming healthcare systems, improving outcomes, and leading interdisciplinary teams. Learn more about the panel: https://lnkd.in/eB3ypF8p